The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients-Reference-Cited by-同舟云学术

The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients

Published:2014-01-28 Issue:3 Volume:28 Page:365-376
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Linas Benjamin P.,Barter Devra M.,Leff Jared A.,DiLorenzo Madeline,Schackman Bruce R.,Horsburgh Charles R.,Assoumou Sabrina A.,Salomon Joshua A.,Weinstein Milton C.,Kim Arthur Y.,Freedberg Kenneth A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference75 articles.

1. HIV-HCV co-infection facing HCV protease inhibitor licensing: implications for clinicians.;Ingiliz;Liver Int,2012

2. Combination therapy with TVRaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.;Sulkowski;Ann Intern Med,2013

3. Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.;Sulkowski;Lancet Infect Dis,2013

4. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.;Jacobson;N Engl J Med,2013

5. Sofosbuvir for previously untreated chronic hepatitis C infection.;Lawitz;N Engl J Med,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs;Trials;2023-09-26

2. Healthcare resource utilization in Hepatitis C-infected patients completing eight versus twelve weeks of treatment: A retrospective cohort study;Frontiers in Gastroenterology;2022-09-15

3. Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future;Journal of Substance Abuse Treatment;2020-03

4. Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons;Clinical Infectious Diseases;2019-05-16

5. Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population;Infectious Diseases and Therapy;2019-03-02